$0.00
FOXO4 | 10mg
$169.00
5 in stock
Description
FOXO4-DRI is a synthetic D-retro-inverso peptide designed to selectively induce apoptosis in senescent cells by disrupting the interaction between FOXO4 and p53. This targeted approach to senolytic therapy is studied for its role in promoting cellular rejuvenation, extending lifespan in preclinical models, and reducing markers of aging-related dysfunction. Its mechanism of action is of interest in regenerative and anti-aging research.
Quantity:
10mg per vial
Purity:
≥99% (HPLC Verified)
Format:
Lyophilized powder
Storage:
Store at -20°C, protect from light and moisture
Solvent:
Bacteriostatic Water
Concentration:
Add 1mL BAC water = 10mg/mL solution
Stability:
Store reconstituted vial at 2°C–8°C and use within 30 days
Dose:
2mg = 0.2mL = ~20 units (using 100iu insulin syringe)
Frequency:
1x daily or every other day in intermittent cycles (e.g. 5 days on, 2 off)
Dosing based on 10mg/mL concentration. For laboratory reference use only.
Research Use:
Not for human or veterinary use. For educational and laboratory study only.
Qualified Use:
For licensed researchers and laboratory professionals
Scientific Basis:
Information reflects preclinical models of senolytic and anti-aging therapies
Reminder:
Do not misbrand, misuse, or misrepresent this compound
Cell (2017):
PubMed:
Clinical Trials:
Disclaimer
FOXO4-DRI is a research compound not approved for medical use. AlphaBoost supplies this product for research and reference purposes only. It is not for human or veterinary use.
Reviews
There are no reviews yet.